Changes in Quality of Life After Treatment for Non-Melanoma Skin Cancer: A Prospective Cohort Study

Background/Objectives: Non-melanoma skin cancer (NMSC), particularly basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), may adversely affect quality of life (QoL), especially in cosmetically sensitive areas. This study aimed to identify factors associated with QoL in patients with NMSC and to evaluate changes in dermatology- and skin cancer-specific QoL following treatment. Methods: This prospective study included 169 patients with NMSC evaluated at baseline and 3 months after treatment using the Dermatology Life Quality Index (DLQI) and Skin Cancer Quality of Life Impact Tool (SCQOLIT). Factors associated with baseline QoL and changes according to treatment modality and histological subtype were analysed. Results: The mean age was 69.2 ± 11.85 years; 82.8% had BCC and 17.2% had SCC. Mean DLQI scores decreased from 2.29 ± 2.81 to 0.34 ± 0.75 and SCQOLIT scores from 4.78 ± 5.53 to 1.20 ± 1.76 at 3 months (both p < 0.001). Lower educational level was associated with higher baseline DLQI scores, whereas younger age and higher socioeconomic status were associated with higher and lower baseline SCQOLIT scores, respectively; these associations persisted in sensitivity analyses. The associations of younger age, female sex, and SCC histology with higher DLQI scores were less robust. SCC patients had higher baseline DLQI scores than BCC patients (3.66 ± 4.82 vs. 2.01 ± 2.10, p = 0.040), but this difference was no longer statistically significant at 3 months. QoL improved following both surgical and medical treatment, with no significant differences in the magnitude of improvement among surgical or medical treatment types. Conclusions: QoL improved significantly within 3 months after NMSC treatment. Different factors were associated with baseline DLQI and SCQOLIT scores, suggesting that these instruments may capture complementary aspects of QoL. Their combined use may provide a more comprehensive assessment of patients with NMSC.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-10-13
DOI
https://doi.org/10.3390/jcm15207890
Primary Topic
Nonmelanoma Skin Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Changes in Quality of Life After Treatment for Non-Melanoma Skin Cancer: A Prospective Cohort Study

Kenan Aydoğan, Beyhan Cengiz Özyurt, Serkan Yazıcı, Hayriye Sarıcaoğlu et al.
Journal of Clinical Medicine
Nonmelanoma Skin Cancer Studies
article

Changes in Quality of Life After Treatment for Non-Melanoma Skin Cancer: A Prospective Cohort Study

Kenan Aydoğan, Beyhan Cengiz Özyurt, Serkan Yazıcı, Hayriye Sarıcaoğlu, Zehra Neslisah UNAN, Süleyman Çeçen, Ümmühan Şeker, Ferdi Öztürk, Egenaz Şenol Okan
article en

Abstract

Background/Objectives: Non-melanoma skin cancer (NMSC), particularly basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), may adversely affect quality of life (QoL), especially in cosmetically sensitive areas. This study aimed to identify factors associated with QoL in patients with NMSC and to evaluate changes in dermatology- and skin cancer-specific QoL following treatment. Methods: This prospective study included 169 patients with NMSC evaluated at baseline and 3 months after treatment using the Dermatology Life Quality Index (DLQI) and Skin Cancer Quality of Life Impact Tool (SCQOLIT). Factors associated with baseline QoL and changes according to treatment modality and histological subtype were analysed. Results: The mean age was 69.2 ± 11.85 years; 82.8% had BCC and 17.2% had SCC. Mean DLQI scores decreased from 2.29 ± 2.81 to 0.34 ± 0.75 and SCQOLIT scores from 4.78 ± 5.53 to 1.20 ± 1.76 at 3 months (both p < 0.001). Lower educational level was associated with higher baseline DLQI scores, whereas younger age and higher socioeconomic status were associated with higher and lower baseline SCQOLIT scores, respectively; these associations persisted in sensitivity analyses. The associations of younger age, female sex, and SCC histology with higher DLQI scores were less robust. SCC patients had higher baseline DLQI scores than BCC patients (3.66 ± 4.82 vs. 2.01 ± 2.10, p = 0.040), but this difference was no longer statistically significant at 3 months. QoL improved following both surgical and medical treatment, with no significant differences in the magnitude of improvement among surgical or medical treatment types. Conclusions: QoL improved significantly within 3 months after NMSC treatment. Different factors were associated with baseline DLQI and SCQOLIT scores, suggesting that these instruments may capture complementary aspects of QoL. Their combined use may provide a more comprehensive assessment of patients with NMSC.

Journal of Clinical MedicineVol. 15(20)
Bursa Uludağ Üni̇versi̇tesi̇ (TR), Manisa Celal Bayar University (TR), State Hospital (GB), Sivas State Hospital (TR)
Openalex Percentile: Top 12%
Nonmelanoma Skin Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.